5Swain S M, Whaley F S, Ewer M S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trails[J]. Cancer, 2003,97 ( 11 ) : 2869- 2879.
6Gianni L,Munzone E, Capri G, et al. Paclitaxel by 3 hour in fusion with bolus doxorubincin in womem with untreated meta- static breast cancer: high antitumor efficacy and cardiac effects in a dose finding and sequence-finding study[J]. J Clin Oneol, 1995,13 ( 11 ) : 2688-2699.
7Tepler I, Elias L, Smith JW, et al. A randomized placebo-controlled trial of recombinsnt human interliukin-11 in canear patients with severe thrombocytopenia due to chemotherapy[J]. Blood, 1996, 87(9): 3607-3614.
8Isaaes C, Robert NJ, Bailey FA, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin[J]. J Clin Oncol, 1997, 15(11): 3368-3377.
9Perez EA, Lembersky B, Kaywin P, et al. Intravenous(IV) granisetron vs ondansetron in the prevention of cyclophosphamide-doxorubicin-induced emesis in breast cancer patients: a double blind crossover study[J]. Proc Am Soc Clin Oncol, 1996, 15: 543.
10Perez EA, Hesketh P, Sandbach J, et al. Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetngenic chemotherapy: a multicenter, double-blind, randimized parallel study[J]. J Clin Oncol, 1998, 16(2): 754-760.
